BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

16 related articles for article (PubMed ID: 11712084)

  • 1. Fluorescence in situ hybridization to assess transitional changes of aneuploidy for chromosomes 7, 8, 10, 12, 16, X and Y in metastatic prostate cancer following anti-androgen therapy.
    Kasahara K; Taguchi T; Yamasaki I; Karashima T; Kamada M; Yuri K; Shuin T
    Int J Oncol; 2001 Sep; 19(3):543-9. PubMed ID: 11494034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Numerical chromosomal changes in metastatic prostate cancer following anti-androgen therapy: fluorescence in situ hybridization analysis of 5 Japanese cases.
    Karashima T; Taguchi T; Yoshikawa C; Kamada M; Kasahara K; Yuri K; Shuin T
    Cancer Genet Cytogenet; 2000 Jul; 120(2):148-54. PubMed ID: 10942807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer.
    Hiratsuka J; Jo Y; Yoshida K; Nagase N; Fujisawa M; Imajo Y
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):684-90. PubMed ID: 15183471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [High-dose rate iridium-192 brachytherapy combined with external beam radiotherapy for localized prostate cancer].
    Kasahara K; Inoue K; Karashima T; Inoue Y; Kariya S; Inomata T; Yoshida S; Shuin T
    Nihon Hinyokika Gakkai Zasshi; 2001 Jul; 92(5):572-8. PubMed ID: 11517568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose-rate brachytherapy in the treatment of carcinoma of the prostate.
    Syed AM; Puthawala A; Sharma A; Gamie S; Londrc A; Cherlow JM; Damore SJ; Nazmy N; Sheikh KM; Ko SJ
    Cancer Control; 2001; 8(6):511-21. PubMed ID: 11807421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early reduction in the aneuploidy at chromosomes 7 and 8 are significantly correlated with clinical effect in high-dose rate brachytherapy with external beam radiotherapy in localized prostate cancer.
    Kasahara K; Taguchi T; Inoue K; Shuin T; Kariya S; Yoshida S; Furihata M
    Int J Mol Med; 2001 Dec; 8(6):667-73. PubMed ID: 11712084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results.
    Demanes DJ; Rodriguez RR; Schour L; Brandt D; Altieri G
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1306-16. PubMed ID: 15817332
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.